Insider Transactions in Q4 2022 at Magenta Therapeutics, Inc. (MGTA)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Nov 30 2022	Kristen Stants Chief People Officer	BUY Grant, award, or other acquisition	Direct	3,000 +12.9%	$0 $0.94 P/Share
Nov 30 2022	Jason Gardner Director	BUY Grant, award, or other acquisition	Direct	3,000 +1.01%	$0 $0.94 P/Share
Nov 30 2022	Caren Deardorf Chief Commercial Officer	BUY Grant, award, or other acquisition	Direct	3,000 +13.18%	$0 $0.94 P/Share
Nov 30 2022	Stephen F. Mahoney Officer	BUY Grant, award, or other acquisition	Direct	3,000 +14.8%	$0 $0.94 P/Share
Nov 30 2022	Thomas W. Beetham Officer	BUY Grant, award, or other acquisition	Direct	3,000 +13.1%	$0 $0.94 P/Share

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Value

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

Operation

Value

Type

Receive news related to Magenta Therapeutics, Inc.